ArticleJournal of clinical medicine2026
Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer.
Süleyman Can, Veli Çakıcı, Gizem Bakır Kahveci, Şeyma Eroğlu, Burak Tok, Gökhan Uygun, Esra Özer, Yalçın Çırak, İvo Gökmen
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Süleyman CanDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.ORCID 0009-0000-9172-8571 Veli ÇakıcıDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.ORCID 0000-0002-8327-7659 Gizem Bakır KahveciDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Trakya University, Edirne 22030, Türkiye.
Şeyma EroğluDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.ORCID 0000-0002-7886-3872 Burak TokDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.
Gökhan UygunDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.
Esra ÖzerDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.ORCID 0009-0001-9014-1784 Yalçın ÇırakDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.
İvo GökmenDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.ORCID 0000-0002-0382-5396 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bevacizumabmetastatic colorectal cancermucinous histologyperitoneal metastasisprogression-free survival
Identifiers
PMID41977106
PMCPMC13073025
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390